Simon Cheesman speaks to ecancer at the 2019 Biosimilars Educational Advanced Masterclass for Pharmacists (P-BEAM) in Zurich about how real-world data generation can assist biosimilar implementation.

He explains that there are potential barriers to biosimilar adoption varying from national to local.

He believes that real-world data has provided confidence that patients are not being disadvantaged by using a biosimilar.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.

If you would like to learn more about biosimilar medicines, please visit our free e-learning modules here.